Election 2014
SENSEX NIFTY

Vaccine

Nov 23, 2013 at 16:38 | Source: CNBC-TV18
Malaria vaccine is a good example of the company's broad commitment to innovate and improve access to medicine and healthcare for people. It is not just a programme or a PR campaign, said GSK CEO, Andrew Witty.
Oct 08, 2013 at 08:37 | Source: Reuters
The vaccine known as RTS,S was found, after 18 months of follow-up, to have almost halved the number of malaria cases in young children in the trial, and to have reduced by around a quarter the number of malaria cases in infants.
Sep 30, 2013 at 22:09 | Source: CNBC-TV18
Viebacher's views on regulatory hurdles in India were evidence of the long drawn tax liability battle it has waged against the Indian IT department over the acquisition of Indian vaccine maker Shantha Biotech.
Aug 12, 2013 at 13:47 | Source: PTI
A new malaria vaccine, which is being developed in the US, has shown promising results in early stage clinical trials, scientists say. Researchers found that high doses of the vaccine protected 12 out of 15 patients from the disease.
Jul 25, 2013 at 11:06 | Source: Moneycontrol.com
In the unique partnership, Zydus and IDRI are collaborating on the production and clinical development of IDRIs visceral leishmaniasis vaccine candidate, designed to prevent the deadly parasitic disease.
Jul 18, 2013 at 12:29 | Source: Moneycontrol.com
Lupin gets a non-exclusive license to market MSD's pneumococcal polysaccharide vaccine under a different brand name in India.
Jul 08, 2013 at 15:20 | Source: PTI
Drug major Novartis joined hands with Biological E (BioE) for two vaccines against typhoid and paratyphoid fevers. Hyderabad-based BioE will have financial and operational responsibility for manufacturing, further clinical development, approval and distribution in the developing world.
Jun 19, 2013 at 17:48 | Source: CNBC-TV18
Shantha Biotech's Shan-5, its 5-in-1 vaccine, disqualified by the WHO on quality concerns, is now up for reassesment.
Jun 16, 2013 at 21:30 | Source: PTI
Concerned over spate of acquisitions of domestic pharma firms by multinationals, the Department of Industrial Policy and Promotion will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
May 23, 2013 at 13:55 | Source: Reuters
Methicillin-resistant Staphylococcus aureus infects an estimated 53 million people globally and costs more than USD 20 billion a year to treat. In the United States alone, MRSA kills 20,000 Americans each year, exceeding annual deaths from AIDS.
Messages on Vaccine »

sathiboy

Gold Member

15 Followers

Panacea Biotec  

India’s largest vaccine maker and Panacea’s arch-rival Cyrus Poonawalla led Serum Institute of India acquiring Panacea’s shares from open market . Serum Institute’s stake in Panacea Biotech increased from less than 4% in 2008 to the highest level of 13.39 % .They started accumulation even

12.08 PM Apr 15th

a trader

Silver Member

0 Follower

Ashco Niulab  

MUMBAI: The service tax department on Thursday arrested Ashok Kotwani, managing director of Ashco Niulab Industries Ltd, for Rs 4.64 crore evasion from April 2007-September 2013. The company, which provides clinical testing and trial services for newly developed drugs and vaccines on human trial

2.26 PM Apr 13th

avin 57

Platinum Member

486 Followers

Reliance  

our spiritual leaders are mini politicians....ERADICATE POLIO....for them SAVE POLIO AFFECTED SOCIETY...what RIL has done after bonus vaccine...avin 57

6.53 PM Apr 5th

avin 57

Platinum Member

486 Followers

Reliance  

maxim,,,our spiritual leaders are mini politicians....ERADICATE POLIO....for them SAVE POLIO AFFECTED SOCIETY...what RIL has done after bonus vaccine...avin 57

4.51 PM Apr 5th

avin 57

Platinum Member

486 Followers

Politics  

",UID,Bankrupting the Nation in collusion with the International Bankers, Dislocating Citizens of India from their places of birth,"REFORMS",GLOBALIZATION,DEPOPULATION(EUGENICS) and profit for the Pharma industry, misusing Vaccination,Bio-Terror like Bird-,Swine-,etc- Flus,Free Trade,NGOs,the Philanthropic Foundations

11.23 AM Apr 5th

Panacea Biotec  

bahot khub, analysis ko bhi proper vaccination ki jaroorat hai!

2.36 PM Apr 2nd

rajcarmel

Platinum Member

164 Followers

Panacea Biotec  

Buy and Accumulate PANACEA Biotech for long term.One will need a great patience with this firm, which may scale to 125 to 135 in short term.But real benefit will come when you hold it for 5 to 10 years.Vaccination are common norm now.Every new born gets it, even in government hospital they provide

2.32 PM Apr 2nd

sensational
l

Silver Member

15 Followers

Wockhardt  

Wow ! Thanks A159 for such a comprehensive info!!! Excerpt... "The co. has 12 manufacturing plants spread across India, UK, Ireland, France and US. It produces formulations, biopharmaceuticals, vaccines and active pharmaceutical ingredients (APIs). Promoters plan, post 2008 financial crisis

8.29 PM Mar 1st

Panacea Biotec  

140 rate bahut accha! Order Philipines or Indonesia, koi to dedo yaar! ye Company ka sales to ekdam ruka hua hai! nahi to sab share holders ne dus dus vaccine kharido, to kuch to bikega!

1.39 PM Feb 24th

Web Messenger

Platinum Member

208633 Followers

Panacea Biotec  

Source:The Hindu BusinessLine - Panacea Biotec has received an order from Unicef for supply of its DTB-HebB-Hib (Pentavalent) Vaccine Easyfive-TT drug during the period 2014-16. The company, however, clarified that Unicef is yet to award a part of the total forecast quantities for 2014

3.49 PM Feb 14th

News across the web »
Apr 14, 2014 at 10:06 | Source: Economic Times
Apr 13, 2014 at 21:07 | Source: BBC
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.